AI Startups Just Raised Millions to Fix Your Most Annoying Work Problems

On Monday, five small startups announced funding rounds, and they all have one thing in common: they're using AI to tackle hard, expensive problems that companies and people actually face. OneByZero raised $20 million to help businesses plug AI into their existing systems and control what those AI "agents" (AI that can take actions for you) are allowed to do. Pandektes got €13.5 million to build a better legal research tool. Fleuret AI raised €4 million to automate penetration testing—the process of finding security holes before hackers do.

Why does this matter to you? Because these are the kinds of tools that could eventually make your work life easier and safer. Imagine AI that doesn't just answer questions but actually does tasks—like checking contracts, monitoring your company's security, or helping doctors manage patient care. Investors are pouring money into the "plumbing" that makes AI reliable inside real organizations, not just the flashy chatbots.

The two healthcare deals—At Home Harmony ($5 million) and Celaid Therapeutics (¥400 million, about $2.6 million)—show that AI and biotech are also attracting cash for senior care and cell therapy. These are long-term bets on improving health and reducing costs.

The catch? This is still early-stage investing. Most of these companies are small, and their products may take years to reach you. Also, the total amount raised is modest—about $45 million combined—so it's not a sign of a huge boom. But it does show where smart money is going: toward AI that solves specific, costly headaches, not just general intelligence.